Tacrolimus
Prograf, Astagraf XL, Envarsus XR, Protopic, FK506, and generics
Immunosuppressant
| C | 2 | Yes | Yes | Yes |
| Key |
- Caps (Prograf and generics): 0.5, 1, 5 mg
- Extended release caps (Astagraf XL): 0.5, 1, 5 mg (Q24 hr dosing; see remarks)
- Extended release tabs (Envarsus XR): 0.75, 1, 4 mg (Q24 hr dosing; see remarks)
- Oral suspension: 0.5, 1 mg/mL
- Injection (Prograf): 5 mg/mL (1 mL); contains alcohol and polyoxyl 60 hydrogenated castor oil (cremophor)
- Topical ointment (Protopic and generics): 0.03%, 0.1% (30, 60, 100 g)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Tacrolimus." Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309036/all/Tacrolimus.
Tacrolimus. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309036/all/Tacrolimus. Accessed September 9, 2026.
Tacrolimus. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309036/all/Tacrolimus
Tacrolimus [Internet]. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. [cited 2026 September 09]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309036/all/Tacrolimus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tacrolimus
ID - 309036
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309036/all/Tacrolimus
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -

Harriet Lane Handbook

